PPARG and cancer: A subsequent flurry of papers described these activities more widely and fuelled further enthusiasm for differentiation therapy, as the ligands for the PPARγ were seen as well tolerated and in several cases well-established in other therapeutic contexts.This initial enthusiasm and promise was somewhat tempered by contradictory findings in several murine cancer models and equivocal trial findings.